Click a link below to view the mailing archive as if it had been sent to you.
| 2022-01-31 12:15 | | A NASH player touts positive PhIII data, but true test still lies ahead and more... |
| 2022-01-30 12:15 | | Could Moderna Beat Novavax to Market With a COVID-Flu Vaccine? and more... |
| 2022-01-28 12:15 | | Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA and more... |
| 2022-01-28 00:15 | | Cortexyme to shift focus after FDA places hold on experimental Alzheimer's drug and more... |
| 2022-01-27 12:15 | | Pfizer wants to help the FDA with its new, court-mandated $4-5M FOIA release on the company's Covid-19 vaccine data and more... |
| 2022-01-26 12:15 | | Gilead's $4.9B oncology bet hit with partial clinical hold, forcing pause of pivotal trials and raising doubts about CD47 and more... |
| 2022-01-26 00:15 | | J&J 'constantly looking' at biotech M&A, but focused on small, mid-sized deals and more... |
| 2022-01-25 12:15 | | Pfizer, BioNTech launch trial for potential omicron-busting vaccine and more... |
| 2022-01-25 00:15 | | Medtronic Recalls Atherectomy Device After Patient Injuries and more... |
| 2022-01-24 12:15 | | Merck: FDA Rejects Gefapixant Application, Requests More Data and more... |
| 2022-01-23 00:15 | | 3 Clinical Trials to Watch in the First Half of 2022 and more... |
| 2022-01-21 12:15 | | Confidence is high for Eli Lilly CEO Ricks in showdown with Biogen's Aduhelm and more... |
| 2022-01-21 00:15 | | 27 drugmakers to provide generic COVID drug to low-income countries and more... |
| 2022-01-20 12:15 | | Califf on accelerated approvals: Companies need to do more work before FDA says OK and more... |
| 2022-01-20 00:15 | | Secondary patents prove to be key in biosimilar blocking strategies, researchers find and more... |
| 2022-01-19 12:15 | | UCB to buy Zogenix for nearly $2B in 'first step' for M&A in 2022 and more... |
| 2022-01-19 00:15 | | With $825M SPAC merger, ProKidney sets stage for phase 3 trial of kidney disease cell therapy and more... |
| 2022-01-18 12:15 | | The top 10 biopharma M&A deals in 2021 and more... |
| 2022-01-18 00:15 | | Moderna CEO says data for Omicron-specific shot likely available in March and more... |
| 2022-01-17 12:15 | | Novo Nordisk comes out clean in $1.8B investor lawsuit alleging insulin misdirection and more... |
| 2022-01-16 12:15 | | Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust case and more... |
| 2022-01-15 00:15 | | Biogen compiles buyout target list as Aduhelm woe deepens: Stat |
| 2022-01-14 12:15 | | Why Pfizer and BioNTech Got Thrashed on Thursday and more... |
| 2022-01-14 00:15 | | Despite Supreme Court Ruling, Many Employers Will Still Mandate Covid Vaccines and more... |
| 2022-01-13 12:15 | | JPM22, Day 4: Vertex aims to be cystic fibrosis leader into the 2030s; Gritstone hopes for new colorectal cancer biomarker and more... |
| 2022-01-13 00:15 | | Virus may infect most, Fauci says, but risk of severe illness 'very, very low’ for vaccinated and more... |
| 2022-01-12 12:15 | | JPM22, Day 3: BeiGene, Ionis promise 'tidal wave' of new drugs; Roche launches smart, point-of-care glucose monitor and more... |
| 2022-01-12 00:15 | | Health tech M&A is heating up and more... |
| 2022-01-11 12:15 | | JPM22, Day 2: Freenome passes $1B funding mark; Amgen spices things up with Arrakis; Sage touts double-duty anxiety drug and more... |
| 2022-01-11 00:15 | | JPM22: Pfizer's big bet on mRNA, Biogen 'proven wrong' on Aduhelm price and the next cell therapies and more... |
| 2022-01-10 12:15 | | Maze Therapeutics navigates $190M financing round as it plots course to the clinic and more... |
| 2022-01-07 12:15 | | Judge: FDA Cannot Have Until 2076 to Disclose Pfizer/BioNTech Vaccine Data and more... |
| 2022-01-07 00:15 | | Stryker Takes the Digital Route with New M&A and more... |
| 2022-01-06 12:15 | | AstraZeneca, Amgen tap Brand Institute in new naming twist for their freshly approved Tezspire and more... |
| 2022-01-06 00:15 | | CDC recommends Pfizer COVID booster for kids as young as 12 and more... |
| 2022-01-05 12:15 | | Pfizer, BioNTech to develop shingles shot, after COVID-19 vaccine success and more... |
| 2022-01-05 00:15 | | Pfizer carries pandemic momentum into 2022, scoring another huge Paxlovid deal with the US and more... |
| 2022-01-04 12:15 | | Novartis blocks generic to MS blockbuster Gilenya in US patent dispute and more... |
| 2022-01-04 00:15 | | Jury finds Theranos founder Elizabeth Holmes guilty of fraud and more... |
| 2022-01-03 12:15 | | FDA authorizes first Covid-19 booster shot for teens aged 12 to 15 and more... |
| 2022-01-03 00:15 | | France Rejects Merck's COVID-19 Pill: How Bad Is the News? and more... |
